| 000 | 01541 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516175852.0 | ||
| 264 | 0 | _c20150930 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1559-0267 | ||
| 024 | 7 |
_a10.1007/s12016-013-8393-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlbertson, T E | |
| 245 | 0 | 0 |
_aPharmacotherapy of critical asthma syndrome: current and emerging therapies. _h[electronic resource] |
| 260 |
_bClinical reviews in allergy & immunology _cFeb 2015 |
||
| 300 |
_a7-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aCritical Illness |
| 650 | 0 | 4 |
_aDrug Therapy _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin E _ximmunology |
| 650 | 0 | 4 | _aImmunomodulation |
| 650 | 0 | 4 | _aOmalizumab |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 |
_aRespiratory System _xdrug effects |
| 650 | 0 | 4 | _aSyndrome |
| 700 | 1 | _aSchivo, M | |
| 700 | 1 | _aGidwani, N | |
| 700 | 1 | _aKenyon, N J | |
| 700 | 1 | _aSutter, M E | |
| 700 | 1 | _aChan, A L | |
| 700 | 1 | _aLouie, S | |
| 773 | 0 |
_tClinical reviews in allergy & immunology _gvol. 48 _gno. 1 _gp. 7-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12016-013-8393-8 _zAvailable from publisher's website |
| 999 |
_c23219787 _d23219787 |
||